Lenalidomide 25 MG Oral Capsule

DRUG2 trials

Sponsors

Starton Therapeutics, Inc, Erasmus Medical Center

Conditions

HivMultiple Myeloma

Phase 1

Safety, Efficacy, and Pharmacokinetics of Continuous Subcutaneous Lenalidomide in Multiple Myeloma (MM)

RecruitingNCT06087653

Starton Therapeutics, IncMultiple Myeloma

Start: 2023-10-02End: 2028-03-31Target: 24Updated: 2026-08-24

Optimizing Reversal of HIV Latency With Combination Therapy

Not yet recruitingNCT06240520

Erasmus Medical CenterHiv

Start: 2024-04-30End: 2025-10-31Target: 49Updated: 2024-02-05